Joseph Truitt, iECURE CEO
Exclusive: Jim Wilson startup gets FDA green light for first test of gene editing in babies
Nearly 25 years ago, a young man with an inherited liver disease died from a vicious immune reaction to an experimental gene therapy. Now Jim …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
